Science 37 Overview
- Year Founded
-
2014

- Status
-
Public
- Employees
-
460

- Stock Symbol
-
SNCE

- Investments
-
2
- Share Price
-
$0.24
- (As of Wednesday Closing)
Science 37 General Information
Description
Science 37 Holdings Inc is engaged in the development of new and innovative treatments that impact patient lives. It enables universal access to patients and providers for clinical trials. Its Operating System is fused with networks of telemedicine investigators, mobile nurses, remote coordinators, patient communities and connected devices.
Contact Information
- 600 Corporate Pointe
- Suite 320
- Culver City, CA 90230
- United States
Science 37 Timeline
Science 37 Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.24 | $0.24 | $0.19 - $0.70 | $28.7M | 119M | 207K | -$1.07 |
Science 37 Financials Summary
In Thousands, USD |
TTM 30-Sep-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|---|
EV | (17,130) | (80,313) | 1,430,398 | |
Revenue | 60,261 | 70,147 | 59,597 | 23,704 |
EBITDA | (122,268) | (34,831) | (86,534) | (27,304) |
Net Income | (124,651) | (50,988) | (94,331) | (31,674) |
Total Assets | 75,727 | 126,448 | 260,798 | 57,031 |
Total Debt | 581 | 1,322 | 2,442 | 2,481 |
Science 37 Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Science 37 Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Science 37 Comparisons
Industry
Financing
Details
Science 37 Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Medable | Venture Capital-Backed | Palo Alto, CA | 000 | 00000 | 00000000000 | 00000 |
000000 000000 0000 | Venture Capital-Backed | Austin, TX | 000 | 00000 | 000000000 | 00000 |
00000 000000 | Venture Capital-Backed | San Francisco, CA | 00 | 000.00 | 00000000000 | 000.00 |
00 0000000000 | Venture Capital-Backed | Solana Beach, CA | 00 | 000.00 | 00000000000 | 000.00 |
0000000 000000 | Venture Capital-Backed | San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
Science 37 Executive Team (38)
Science 37 Board Members (14)
Name | Representing | Role | Since |
---|---|---|---|
Bhooshi De Silva | Pharmaceutical Product Development | Board Member | 000 0000 |
Bhooshitha De Silva | Science 37 | Board Member | 000 0000 |
David Coman | Science 37 | Chief Executive Officer & Board Member | 000 0000 |
Emily Rollins | Science 37 | Board Member | 000 0000 |
Itai Danovitch MD | Science 37 | Board Member | 000 0000 |
Science 37 Signals
Science 37 Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Science 37 Investments & Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Vault Health(life science platform) | 02-Feb-2023 | 000000000 | Laboratory Services (Healthcare) | 00000 000 | |
LifeSci Acquisition II | 06-Oct-2021 | Merger/Acquisition | 00.000 | Special Purpose Acquisition Company (SPAC) | 00000 000 |
Science 37 ESG
Risk Overview
Risk Rating
Updated June, 21, 2023
23.99 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,708
Rank
Percentile

Commercial Services
Industry
00 of 452
Rank
Percentile

Business Support Services
Subindustry
00 of 174
Rank
Percentile
